Literature DB >> 22431251

Cluster analysis of autistic patients based on principal pathogenetic components.

Roberto Sacco1, Carlo Lenti, Monica Saccani, Paolo Curatolo, Barbara Manzi, Carmela Bravaccio, Antonio M Persico.   

Abstract

We have recently described four principal pathogenetic components in autism: (I) circadian and sensory dysfunction, (II) immune abnormalities, (III) neurodevelopmental delay, and (IV) stereotypic behaviors. Using hierarchical and k-means clustering, the same 245 patients assessed in our principal component analysis can be partitioned into four clusters: (a) 43 (17.6%) have prominent immune abnormalities accompanied by some circadian and sensory issues; (b) 44 (18.0%) display major circadian and sensory dysfunction, with little or no immune symptoms; (c) stereotypies predominate in 75 (31.0%); and (d) 83 (33.9%) show a mixture of all four components, with greater disruptive behaviors and mental retardation. The "immune" component provides the largest contributions to phenotypic variance (P = 2.7 x 10(-45)), followed by "stereotypic behaviors." These patient clusters may likely differ in genetic and immune underpinnings, developmental trajectories, and response to treatment.
© 2012 International Society for Autism Research, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22431251     DOI: 10.1002/aur.1226

Source DB:  PubMed          Journal:  Autism Res        ISSN: 1939-3806            Impact factor:   5.216


  23 in total

1.  Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma.

Authors:  Marjannie Eloi Akintunde; Melissa Rose; Paula Krakowiak; Luke Heuer; Paul Ashwood; Robin Hansen; Irva Hertz-Picciotto; Judy Van de Water
Journal:  J Neuroimmunol       Date:  2015-07-11       Impact factor: 3.478

2.  Anti-brain antibodies are associated with more severe cognitive and behavioral profiles in Italian children with Autism Spectrum Disorder.

Authors:  I S Piras; L Haapanen; V Napolioni; R Sacco; J Van de Water; A M Persico
Journal:  Brain Behav Immun       Date:  2014-01-03       Impact factor: 7.217

3.  Clustering of co-occurring conditions in autism spectrum disorder during early childhood: A retrospective analysis of medical claims data.

Authors:  Troy Vargason; Richard E Frye; Deborah L McGuinness; Juergen Hahn
Journal:  Autism Res       Date:  2019-05-31       Impact factor: 5.216

4.  Homogeneous Subgroups of Young Children with Autism Improve Phenotypic Characterization in the Study to Explore Early Development.

Authors:  Lisa D Wiggins; Lin H Tian; Susan E Levy; Catherine Rice; Li-Ching Lee; Laura Schieve; Juhi Pandey; Julie Daniels; Lisa Blaskey; Susan Hepburn; Rebecca Landa; Rebecca Edmondson-Pretzel; William Thompson
Journal:  J Autism Dev Disord       Date:  2017-11

Review 5.  Pharmacogenomic medicine in autism: challenges and opportunities.

Authors:  Katherine Bowers; Ping-I Lin; Craig Erickson
Journal:  Paediatr Drugs       Date:  2015-04       Impact factor: 3.022

6.  Comorbidity clusters in autism spectrum disorders: an electronic health record time-series analysis.

Authors:  Finale Doshi-Velez; Yaorong Ge; Isaac Kohane
Journal:  Pediatrics       Date:  2013-12-09       Impact factor: 7.124

Review 7.  Biomarkers in autism spectrum disorder: the old and the new.

Authors:  Barbara Ruggeri; Ugis Sarkans; Gunter Schumann; Antonio M Persico
Journal:  Psychopharmacology (Berl)       Date:  2013-10-06       Impact factor: 4.530

8.  Intestinal Dysbiosis and Yeast Isolation in Stool of Subjects with Autism Spectrum Disorders.

Authors:  Maria Rosaria Iovene; Francesca Bombace; Roberta Maresca; Anna Sapone; Patrizia Iardino; Annarita Picardi; Rosa Marotta; Chiara Schiraldi; Dario Siniscalco; Nicola Serra; Laura de Magistris; Carmela Bravaccio
Journal:  Mycopathologia       Date:  2016-09-21       Impact factor: 2.574

9.  Brain structure and function correlates of cognitive subtypes in schizophrenia.

Authors:  Daniel Geisler; Esther Walton; Melissa Naylor; Veit Roessner; Kelvin O Lim; S Charles Schulz; Randy L Gollub; Vince D Calhoun; Scott R Sponheim; Stefan Ehrlich
Journal:  Psychiatry Res       Date:  2015-08-21       Impact factor: 3.222

10.  A genotype-first approach to defining the subtypes of a complex disease.

Authors:  Holly A Stessman; Raphael Bernier; Evan E Eichler
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.